Baxter International | GJELD



Debt Endring Dato
Abbott USD 14.98B 225M 2024-09
AtriCure USD 70.33M 7.31M 2024-12
Avanos Medical USD 134.7M 27.3M 2024-12
Baxter International USD 13.13B 191M 2024-12
Becton, Dickinson and Co. USD 18.76B 1.35B 2024-12
Boston Scientific USD 10.75B 139M 2024-12
Cooper Companies USD 2.54B 43.8M 2025-01
Dexcom USD 2.5B 2.1M 2024-12
Edwards Lifesciences USD 597.7M 200K 2024-12
Fresenius EUR 13.28B 40M 2024-12
Globus Medical USD 443.88M 5M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
ICU Medical USD 1.59B 11.36M 2024-12
Insulet USD 1.39B 6.2M 2024-12
Integra LifeSciences USD 1.8B 3.5M 2024-12
Intuitive Surgical USD 0 0 2024-09
J&J USD 36.63B 883M 2024-12
Laboratory Of America USD 6.41B 421.6M 2024-12
Masimo USD 765.2M 7.4M 2024-12
Medtronic USD 26.61B 1.72B 2025-01
Merit Medical Systems USD 729.55M 20.95M 2024-12
Quest Diagnostics USD 6.22B 753M 2024-12
Smith & Nephew USD 3.32B 334M 2024-12
Stryker USD 13.6B 1.89B 2024-12
Tandem Diabetes Care USD 348.94M 502K 2024-12
Teleflex USD 1.66B 102.55M 2024-12
Terumo JPY 189.82B 15.02B 2024-12
Zimmer Biomet Holdings USD 6.2B 246.1M 2024-12



Baxter International GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.